These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19976430)

  • 21. Remarks ON THE OPERATIVE CURE OF ASCITES DUE TO LIVER CIRRHOSIS.
    Morison R
    Br Med J; 1912 Jan; 1(2664):113-4. PubMed ID: 20765963
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of umbilical hernia complicated with liver cirrhosis: an advocate of early and elective herniorrhaphy.
    Choi SB; Hong KD; Lee JS; Han HJ; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    Dig Liver Dis; 2011 Dec; 43(12):991-5. PubMed ID: 21872542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A modification of the Crosby-Cooney operation for intractable ascites due to cirrhosis of the liver.
    LORD JW
    J Am Med Assoc; 1948 Mar; 136(11):767. PubMed ID: 18905364
    [No Abstract]   [Full Text] [Related]  

  • 24. [CONTRIBUTION TO THE TREATMENT OF ASCITES IN LIVER CIRRHOSIS WITH ENTECTROPY OF AN ILEAL LOOP].
    JEKLER J; VINCENCOVA B; SETKA J
    Rozhl Chir; 1964 Jan; 43():47-50. PubMed ID: 14111230
    [No Abstract]   [Full Text] [Related]  

  • 25. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
    Pose E; Cardenas A
    Dig Dis; 2017; 35(4):402-410. PubMed ID: 28468013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.
    Smadja C; Franco D
    Ann Surg; 1985 Apr; 201(4):488-93. PubMed ID: 3977450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].
    Jabłkowski M; Białkowska J; Koktysz R; Bartkowiak J; Stankiewicz W; Dworniak D
    Pol Merkur Lekarski; 2004; 17 Suppl 1():149-52. PubMed ID: 15603376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the safety of pure laparoscopic hepatectomy in patients with liver cirrhosis: investigations including serum albumin and ascites.
    Miyagi S; Nakanishi C; Hara Y; Kamei T; Kawagishi N; Ohuchi N
    Surg Laparosc Endosc Percutan Tech; 2015 Jun; 25(3):209-11. PubMed ID: 25856139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated low flow pump system for the treatment of refractory ascites: a single-center experience.
    Thomas MN; Sauter GH; Gerbes AL; Stangl M; Schiergens TS; Angele M; Werner J; Guba M
    Langenbecks Arch Surg; 2015 Dec; 400(8):979-83. PubMed ID: 26566989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ANTETHORACIC OMENTOPEXY IN CIRRHOSIS WITH ASCITES].
    CARSKY K
    Rozhl Chir; 1963 Oct; 42():674-8. PubMed ID: 14119831
    [No Abstract]   [Full Text] [Related]  

  • 31. EXPERIMENTAL ASCITES. V. PRODUCTION OF HEPATIC OUTFLOW BLOCK AND ASCITES WITH A HEPATIC VEIN CHOKER.
    ORLOFF MJ; BADDELEY RM; ROSS TH; NUTTING RO; THOMAS HS; HALASZ NA; SLOOP RD
    Ann Surg; 1965 Feb; 161(2):258-62. PubMed ID: 14260025
    [No Abstract]   [Full Text] [Related]  

  • 32. [HEPATOPEXIA WITH "EASTMAN 910" ASSOCIATED WITH PORTACAVAL ANASTOMOSIS IN THE TREATMENT OF GROSS ASCITES DUE TO HEPATIC CIRRHOSIS].
    BELLI L; FORTI D
    Minerva Chir; 1964 Dec; 19():817-27. PubMed ID: 14243308
    [No Abstract]   [Full Text] [Related]  

  • 33. [Indications for lymphovenous anastomosis for ascites in cirrhosis of the liver].
    Granov AM; Borisov AE; Zemlianoĭ VP; Anisimov VN; Shelukhin AP
    Vestn Khir Im I I Grek; 1982 Jul; 129(7):52-5. PubMed ID: 7123796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The portacaval shunt operation in patients with cirrhosis and ascites.
    BARKER HG; REEMTSMA K
    Surgery; 1960 Jul; 48():142-54. PubMed ID: 13796811
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of cirrhosis of the liver and ascites with particular reference to the portacaval shunt operation.
    HABIF DV; RANDALL HT; SOROFF HS
    Surgery; 1953 Sep; 34(3):580-606. PubMed ID: 13090046
    [No Abstract]   [Full Text] [Related]  

  • 36. The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial.
    Casper M; Mengel M; Fuhrmann C; Herrmann E; Appenrodt B; Schiedermaier P; Reichert M; Bruns T; Engelmann C; Grünhage F; Lammert F;
    Trials; 2015 Mar; 16():83. PubMed ID: 25887140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PATHOGENESIS AND CURRENT POSSIBILITIES OF SURGICAL TREATMENT OF ASCITES].
    OSELLADORE G; PEZZUOLI G; BELLI L
    Minerva Med; 1963 Oct; 54():3228-31. PubMed ID: 14102337
    [No Abstract]   [Full Text] [Related]  

  • 38. [EXTRAPERITONIZATION OF THE RIGHT LOBE OF THE LIVER IN THE TREATMENT OF CIRRHOTIC ASCITES].
    BURLUI D; MANESCU
    Presse Med (1893); 1964 Feb; 72():591-4. PubMed ID: 14119701
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction.
    Ryu KW; Lee JH; Kim YW; Park JW; Bae JM
    World J Surg; 2005 May; 29(5):653-6. PubMed ID: 15827849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mesenterico-caval shunt with interposition of a prosthesis for intractable ascites caused by cirrhosis].
    Peracchia A
    Ateneo Parmense Acta Biomed; 1975; 46(3):101-11. PubMed ID: 1156460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.